129 related articles for article (PubMed ID: 33149490)
1. Evaluation of Efficacy of Pilocarpine and Bethanechol in Xerostomic Denture Wearers.
Singh R; Singh R; Singh S; Sinha RI; Kulkarni G; Jois HS
J Pharm Bioallied Sci; 2020 Aug; 12(Suppl 1):S378-S381. PubMed ID: 33149490
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hyposalivation following radiation therapy.
Gorsky M; Epstein JB; Parry J; Epstein MS; Le ND; Silverman S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Feb; 97(2):190-5. PubMed ID: 14970777
[TBL] [Abstract][Full Text] [Related]
3. A clinical study to compare between resting and stimulated whole salivary flow rate and pH before and after complete denture placement in different age groups.
Muddugangadhar BC; Sangur R; Rudraprasad IV; Nandeeshwar DB; Kumar BH
J Indian Prosthodont Soc; 2015; 15(4):356-66. PubMed ID: 26929540
[TBL] [Abstract][Full Text] [Related]
4. Clinical and histological findings of denture stomatitis as related to intraoral colonization patterns of Candida albicans, salivary flow, and dry mouth.
Altarawneh S; Bencharit S; Mendoza L; Curran A; Barrow D; Barros S; Preisser J; Loewy ZG; Gendreau L; Offenbacher S
J Prosthodont; 2013 Jan; 22(1):13-22. PubMed ID: 23107189
[TBL] [Abstract][Full Text] [Related]
5. A study on Evaluation of efficacy of bethanechol in the management of chemoradiation-induced xerostomia in oral cancer patients.
Kavitha M; Mubeen K; Vijayalakshmi KR
J Oral Maxillofac Pathol; 2017; 21(3):459-460. PubMed ID: 29391733
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the 1 and 2% pilocarpine mouthwash in a xerostomic population: a randomized clinical trial.
Motamed B; Alaee A; Azizi A; Jahandar H; Fard MJK; Jafari A
BMC Oral Health; 2022 Dec; 22(1):548. PubMed ID: 36457091
[TBL] [Abstract][Full Text] [Related]
7. A clinical trial of bethanechol in patients with xerostomia after radiation therapy. A pilot study.
Epstein JB; Burchell JL; Emerton S; Le ND; Silverman S
Oral Surg Oral Med Oral Pathol; 1994 Jun; 77(6):610-4. PubMed ID: 7915026
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of unstimulated flow rates of whole and palatal saliva in healthy patients wearing complete dentures and in patients with Sjogren's syndrome.
Márton K; Boros I; Fejérdy P; Madléna M
J Prosthet Dent; 2004 Jun; 91(6):577-81. PubMed ID: 15211301
[TBL] [Abstract][Full Text] [Related]
9. Effect of 0.1% pilocarpine mouthwash on xerostomia: double-blind, randomised controlled trial.
Kim JH; Ahn HJ; Choi JH; Jung DW; Kwon JS
J Oral Rehabil; 2014 Mar; 41(3):226-35. PubMed ID: 24527846
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the use of sialogogues in the clinical management of patients with xerostomia.
Chainani-Wu N; Gorsky M; Mayer P; Bostrom A; Epstein JB; Silverman S
Spec Care Dentist; 2006; 26(4):164-70. PubMed ID: 16927740
[TBL] [Abstract][Full Text] [Related]
11. A randomized phase III prospective trial of bethanechol to prevent radiotherapy-induced salivary gland damage in patients with head and neck cancer.
Jham BC; Teixeira IV; Aboud CG; Carvalho AL; Coelho Mde M; Freire AR
Oral Oncol; 2007 Feb; 43(2):137-42. PubMed ID: 16798061
[TBL] [Abstract][Full Text] [Related]
12. Pilocarpine hydrochloride relieves xerostomia in chronic graft-versus-host disease: a sialometrical study.
Nagler RM; Nagler A
Bone Marrow Transplant; 1999 May; 23(10):1007-11. PubMed ID: 10373066
[TBL] [Abstract][Full Text] [Related]
13. Assessment of whole saliva flow rate in denture wearing patients.
Yurdukoru B; Terzioğlu H; Yilmaz T
J Oral Rehabil; 2001 Jan; 28(1):109-12. PubMed ID: 11298917
[TBL] [Abstract][Full Text] [Related]
14. [Effect of a gel-type denture adhesive on unstimulated whole saliva and minor salivary gland flow rates and on subjective orofacial sicca symptoms].
Demeter T; Houman AB; Gótai L; Károlyházy K; Kovács A; Márton K
Orv Hetil; 2018 Oct; 159(40):1637-1644. PubMed ID: 30277415
[TBL] [Abstract][Full Text] [Related]
15. Mutans streptococci in xerostomic cancer patients after pilocarpine therapy: a pilot study.
Chambers MS; Keene HJ; Toth BB; Lemon JC; Gallagher SC; Martin CG; Martin JW
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Feb; 99(2):180-4. PubMed ID: 15660089
[TBL] [Abstract][Full Text] [Related]
16. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials.
Rieke JW; Hafermann MD; Johnson JT; LeVeque FG; Iwamoto R; Steiger BW; Muscoplat C; Gallagher SC
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):661-9. PubMed ID: 7852133
[TBL] [Abstract][Full Text] [Related]
17. Effect of Pilocarpine on impaired salivary secretion in patients with Sjögren's syndrome.
Jorkjend L; Bergenholtz A; Johansson AK; Johansson A
Swed Dent J; 2008; 32(2):49-56. PubMed ID: 18700333
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of basal and pilocarpine-stimulated salivary flow in primary Sjögren's syndrome. Correlation with clinical, immunological and histological features.
Rosas J; Ramos-Casals M; Ena J; García-Carrasco M; Verdu J; Cervera R; Font J; Caballero O; Ingelmo M; Pascual E
Rheumatology (Oxford); 2002 Jun; 41(6):670-5. PubMed ID: 12048294
[TBL] [Abstract][Full Text] [Related]
19. [A clinical study on the feeling of oral dryness in denture wearers. Part 2. Measurement of the height of the salivary moisture area].
Takayama Y; Nishimura K; Tojo T; Hosoi T
Nihon Hotetsu Shika Gakkai Zasshi; 2005 Apr; 49(2):273-82. PubMed ID: 15858322
[TBL] [Abstract][Full Text] [Related]
20. Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial.
Cifuentes M; Del Barrio-Díaz P; Vera-Kellet C
Br J Dermatol; 2018 Nov; 179(5):1056-1061. PubMed ID: 29432648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
